ATP Synthase Subunit 6 (MT-ATP6) is a mitochondrial DNA-encoded protein that forms part of the F0 channel of ATP synthase (Complex V). It is essential for the final step of oxidative phosphorylation, catalyzing ATP synthesis from ADP using the proton gradient generated by the electron transport chain.
| ATP Synthase Subunit 6 (MT-ATP6) |
|---|
| Gene | [MT-ATP6](/genes/mt-atp6) (mitochondrial) |
| UniProt | [P00846](https://www.uniprot.org/uniprot/P00846) |
| Molecular Weight | ~22.5 kDa |
| Subcellular Localization | Mitochondrial inner membrane |
| Protein Family | ATP synthase subunit a family |
MT-ATP6 is a critical component of the F0 proton channel of ATP synthase:
- Proton Channel: Forms the pore through which protons flow
- Rotary Mechanism: Part of the rotary motor that synthesizes ATP
- Coupling: Couples proton flow to ATP production
- Oligomycin Sensitivity: Confers sensitivity to oligomycin
- Essential for neuronal energy metabolism
- Highly expressed in metabolically active neurons
- Critical for synaptic function
- MT-ATP6 mutations cause Leigh syndrome and Leigh-like phenotypes
- Most common mutation is m.8993T>G
- Causes severe encephalopathy with basal ganglia involvement
¶ NARP (Neuropathy, Ataxia, and Retinitis Pigmentosa)
- MT-ATP6 mutations cause NARP syndrome
- Characterized by neuropathy, ataxia, and retinal degeneration
- Often a milder phenotype than Leigh syndrome
- ATP synthase activity is reduced in AD brains
- MT-ATP6 variants may contribute to energy deficits
- Mitochondrial dysfunction is an early event in AD pathogenesis
- Complex V dysfunction has been reported in PD
- MT-ATP6 variants may modify PD risk
- Alpha-synuclein may interact with ATP synthase
- Coenzyme Q10: May improve ATP production
- Dichloroacetate: Metabolic regulator
- NAD+ precursors: Support mitochondrial metabolism
- Gene therapy for mtDNA mutations
- Small molecule ATP synthase modulators
- Mitochondrial replacement therapy
- MT-ATP6 mutations in Leigh syndrome (2020)
- ATP synthase and neurodegeneration (2019)
- Mitochondrial ATP synthase in Alzheimer's disease (2021)